Samantha Jensen
Nurse Practitioner · Clive, IANPI 1083487920
Payments from drug & device makers
Across 132 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$557
- Johnson & Johnson$481
- Takeda Pharmaceuticals U.S.A., Inc.$305
- Ironwood Pharmaceuticals, Inc$138
- Lilly USA, LLC$136
- Regeneron Healthcare Solutions, Inc.$131
- plus $465 from 7 others
What the payments were for
- Food & beverage$2,07594%
- Education$1396%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $557 |
| Johnson & Johnson | 27 | $481 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $305 |
| Ironwood Pharmaceuticals, Inc | 8 | $138 |
| Lilly USA, LLC | 7 | $136 |
| Regeneron Healthcare Solutions, Inc. | 7 | $131 |
| Celltrion USA Inc. | 6 | $109 |
| Phathom Pharmaceuticals, Inc. | 6 | $109 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $99 |
| Ardelyx, Inc. | 3 | $53 |
| Sanofi | 3 | $48 |
| Bristol Myers Squibb | 2 | $28 |
| Biogen | 1 | $18 |
How this compares
$2,214 in reported general payments places this provider in the 90th percentile of 1,346 nurse practitioner providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 91 | $5,778 |
| Ursodiol | 11 | $1,793 |
| CholestyramineCholestyramine (With Sugar) | 21 | $1,304 |
| Sucralfate | 22 | $1,013 |
| Omeprazole | 42 | $351 |
| Dicyclomine Hcl | 14 | $297 |
| Pantoprazole Sodium | 18 | $274 |
| Famotidine | 29 | $226 |
| Ondansetron OdtOndansetron | 14 | $93 |
| Ondansetron Hcl | 25 | $40 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Clive
- Taylor WhittClive$8K
- Christina HendricksClive$6K
- Nicole MorganDes Moines$106K
- Julie CoffeyIowa City$31K
- Mary JohnsonDavenport$30K
- Megan Hart FernandezCedar Rapids$19K
- Carla HuberCedar Rapids$18K
- Beth ChiaWest Des Moines$15K
- Margaret KinneyRed Oak$13K
- Abbey ModlinDes Moines$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.